Highlander Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $58.6K | Buy |
800
+500
| +167% | +$38.4K | 0.02% | 362 |
|
|
2023
Q4 | $24.3K | Hold |
300
| – | – | 0.01% | 539 |
|
|
2023
Q3 | $22K | Hold |
300
| – | – | 0.01% | 515 |
|
|
2023
Q2 | $23K | Hold |
300
| – | – | 0.01% | 424 |
|
|
2023
Q1 | $25K | Hold |
300
| – | – | 0.01% | 383 |
|
|
2022
Q4 | $26K | Sell |
300
-50
| -14% | -$3.96K | 0.01% | 361 |
|
|
2022
Q3 | $22K | Hold |
350
| – | – | 0.01% | 375 |
|
|
2022
Q2 | $22K | Sell |
350
-260
| -43% | -$16.1K | 0.01% | 389 |
|
|
2022
Q1 | $36K | Hold |
610
| – | – | 0.02% | 331 |
|
|
2021
Q4 | $44K | Hold |
610
| – | – | 0.02% | 300 |
|
|
2021
Q3 | $43K | Hold |
610
| – | – | 0.02% | 301 |
|
|
2021
Q2 | $42K | Hold |
610
| – | – | 0.02% | 315 |
|
|
2021
Q1 | $39K | Hold |
610
| – | – | 0.02% | 314 |
|
|
2020
Q4 | $36K | Hold |
610
| – | – | 0.02% | 323 |
|
|
2020
Q3 | $39K | Hold |
610
| – | – | 0.02% | 314 |
|
|
2020
Q2 | $47K | Buy |
610
+50
| +9% | +$3.83K | 0.03% | 287 |
|
|
2020
Q1 | $42K | Hold |
560
| – | – | 0.03% | 302 |
|
|
2019
Q4 | $36K | Sell |
560
-60
| -10% | -$3.91K | 0.02% | 336 |
|
|
2019
Q3 | $39K | Hold |
620
| – | – | 0.02% | 333 |
|
|
2019
Q2 | $42K | Sell |
620
-100
| -14% | -$6.58K | 0.03% | 339 |
|
|
2019
Q1 | $47K | Hold |
720
| – | – | 0.03% | 332 |
|
|
2018
Q4 | $45K | Sell |
720
-500
| -41% | -$34.9K | 0.03% | 325 |
|
|
2018
Q3 | $94K | Hold |
1,220
| – | – | 0.05% | 268 |
|
|
2018
Q2 | $86K | Hold |
1,220
| – | – | 0.05% | 275 |
|
|
2018
Q1 | $89K | Hold |
1,220
| – | – | 0.05% | 273 |
|
|
2017
Q4 | $87K | Hold |
1,220
| – | – | 0.06% | 273 |
|
|
2017
Q3 | $99K | Hold |
1,220
| – | – | 0.08% | 255 |
|
|
2017
Q2 | $86K | Hold |
1,220
| – | – | 0.07% | 270 |
|
|
2017
Q1 | $83K | Buy |
1,220
+820
| +205% | +$57.7K | 0.07% | 271 |
|
|
2016
Q4 | $29K | Hold |
400
| – | – | 0.03% | 441 |
|
|
2016
Q3 | $32K | Sell |
400
-100
| -20% | -$8.12K | 0.03% | 432 |
|
|
2016
Q2 | $42K | Hold |
500
| – | – | 0.04% | 381 |
|
|
2016
Q1 | $46K | Hold |
500
| – | – | 0.04% | 367 |
|
|
2015
Q4 | $51K | Sell |
500
-500
| -50% | -$52K | 0.05% | 352 |
|
|
2015
Q3 | $98K | Sell |
1,000
-300
| -23% | -$33.3K | 0.09% | 245 |
|
|
2015
Q2 | $152K | Hold |
1,300
| – | – | 0.14% | 178 |
|
|
2015
Q1 | $128K | Buy |
1,300
+600
| +86% | +$60.9K | 0.11% | 210 |
|
|
2014
Q4 | $66K | Buy |
700
+300
| +75% | +$31K | 0.06% | 325 |
|
|
2014
Q3 | $42.6K | Hold |
400
| – | – | 0.04% | 379 |
|
|
2014
Q2 | $33.2K | Buy |
400
+300
| +300% | +$23.4K | 0.03% | 429 |
|
|
2014
Q1 | $7.09K | Buy |
+100
| New | +$7.84K | 0.01% | 715 |
|
Other funds holding GILD
Highlander Capital Management's GILD Position: Q1 2024 in Review
Highlander Capital Management increased its Gilead Sciences (GILD) stake by 167% in Q1 2024, buying an estimated $38.4K and bringing the position to 800 shares worth $58.6K. The position accounts for 0.02% of the portfolio, ranked #362.
Highlander Capital Management first reported a position in GILD in Q1 2014 and has held it in 41 quarters since. The position peaked at $152K in Q2 2015. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Highlander Capital Management held 800 shares of Gilead Sciences worth $58.6K as of Q1 2024.
- Highlander Capital Management bought 500 Gilead Sciences shares in Q1 2024, an estimated $38.4K.
- Gilead Sciences made up 0.02% of Highlander Capital Management's portfolio in Q1 2024, its #362 holding.
- Highlander Capital Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 41 quarters since.
- Highlander Capital Management's Gilead Sciences position peaked at $152K in Q2 2015.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.